Characterization of the Microbiome in Cutaneous T Cell Lymphoma

  • STATUS
    Recruiting
  • End date
    Dec 31, 2023
  • participants needed
    300
  • sponsor
    Northwestern University
Updated on 6 February 2022
lymphoma
skin disorder
psoriasis
phototherapy
lymphoproliferative disorder
anaplastic large cell lymphoma
large cell lymphoma
Accepts healthy volunteers

Summary

Investigators plan to perform a pilot study that aims to characterize the microbiome of human cutaneous T cell lymphoma patients and compare this to the microbiome of age and sex matched controls.

Details
Condition Cutaneous T Cell Lymphoma
Clinical Study IdentifierNCT03932279
SponsorNorthwestern University
Last Modified on6 February 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Group 1: Patients with stage IA-IIA cutaneous T cell lymphoma
Group 2: Patients with stage IIB and above cutaneous T cell lymphoma
Group 3: Patients with CD30+ lymphoproliferative disorder including lymphomatoid papulosis and cutaneous anaplastic large cell lymphoma
Group 4: Patients with plaque psoriasis with BSA>5% on routine phototherapy per standard of care
Group 5: Patients with moderate to severe atopic dermatitis on routine bleach bath therapy per standard of care
Group 6: Healthy individuals without the above skin conditions, similar age and sex distribution to the patients with cutaneous T cell lymphoma
All Groups: subjects who are age 18-89 years of age at time of enrollment
All Groups: Subjects who are able and willing to give informed consent for this study and the Dermatology Tissue Acquisition and Biorepository (STU00009443)

Exclusion Criteria

All Groups: Subjects who are younger than 18 years of age or older than 90 years of age
All Groups: Subjects who are unable to give consent
Patients currently on systemic antibiotics or recent (within past 4 weeks) exposure to systemic antibiotics
We will not recruit the following populations: adults unable to consent, individuals who are not yet adults (infants, children, teenagers), pregnant women, prisoners and other vulnerable populations
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note